The choice between medications should rest primarily on efficacy data, tolerability, availability, and cost rather than the B12 inclusion, which is valuable in both formulations
It modifies the peptide Fragment 176-191f the growth hormone hGH by adding a tyrosine residue to the N-terminus
The dose range is 1.6-4.8 mg per injection: The standard KLOW dose is 3.2 mg total per injection: 2 mg GHK-Cu plus 0.4 mg each of BPC-157, TB-4, and KPV The low-end of the dose range is 1.6 mg, anchored on 1 mg of GHK-Cu with 200 mcg each of BPC-157, TB-4, and KPV The high-end of the dose range is 4.8 mg, anchored on 3 mg of GHK-Cu with 600 mcg each of BPC-157, TB-4, and KPV There is no trial-established dose for KLOW the dose range is mechanistically derived from a combination of each peptide
If poisoning occurs, contact a doctor or Poisons Information Centre